How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

359 results for

bell's palsy guideline

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

141. Management of patients with stroke: rehabilitation, prevention and management of complications, and discharge planning

Management of patients with stroke: rehabilitation, prevention and management of complications, and discharge planning Management of patients with stroke: Rehabilitation, prevention and management of complications, and discharge planning A national clinical guideline June 2010 118 Scottish Intercollegiate Guidelines Network Part of NHS Quality Improvement Scotland SIGN Help us to improve SIGN guidelines - click here to complete our survey KEY TO EVIDENCE STATEMENTS AND GRADES OF RECOMMENDATIONS (...) from studies rated as 1 ++ or 1 + C A body of evidence including studies rated as 2 + , directly applicable to the target population and demonstrating overall consistency of results; or Extrapolated evidence from studies rated as 2 ++ D Evidence level 3 or 4; or Extrapolated evidence from studies rated as 2 + GOOD PRACTICE POINTS ? Recommended best practice based on the clinical experience of the guideline development group NHS Evidence has accredited the process used by Scottish Intercollegiate

2010 SIGN

142. Family Practice Notebook Updates 2016

Do not treat with a single drug regimen until is excluded by history, In suspected , mask patient in negative ariflow room and induce for AFB x3 samples has not changed substantially in 10 years, but multi-drug resistance guidelines are lacking (er, procedure, fen) Quick central access without Seldinger technique (id, std) Syphilis has increased 3-4 fold in the U.S. since 2000 (now at 20,000 cases per year) is typically treated with G (or , ) for primary and secondry Avoid in due to resistance (...) Gradually developed wbc to 3.5k, hgb from 13 to 12 to 11 over 1 week of serial visits for s demonstrated RBC inclusion bodies consistent with Updated to include In failed airway, may temporize in infants and young children for 20-25 min Covers reversal of specific s (e.g. DIC, TTP, disease, renal disease, s) or (id, immunize, ) Very low efficacy in U.S. as of 2016 (as low as 3%) and will not be used in U.S. per ACIP guidelines (endo, pharm, dm) For all its mediocre activity on lowering and adverse

2017 FP Notebook

143. Peripheral facial paralysis

Peripheral facial paralysis © 2010, Dutch College of General Practitioners www.nhg.org august 2010 Peripheral facial paralysis: complete or partial unilateral paralysis of the facial musculature resulting from a functional disorder of the nervus facialis. In case of complete failure of the facial nerve, the facial musculature is completely paralysed, with the corner of the mouth hanging and inability to close the eye on the affected side. Idiopathic peripheral facial paralysis (IPFP, Bell palsy (...) for the presence of blisters; ? the ear for signs of otitis media, otitis externa, the presence of a tumour or cholesteatoma; ? the mouth, tonsil region and neck for the presence of a tumour; ? the ability to close the eyelids and any conjunctival redness. Make the diagnosis of IPFP if the facial paralysis is peripheral, occurred within a short time and if there are no signs of an underlying cause. PERIPHERAL FACIAL PARALYSIS NHG GUIDELINE (summary) M93 TERMS History Physical examination Evaluation DIAGNOSTIC

2010 Dutch College of General Practitioners (NHG)

144. Management of Women with Obesity in Pregnancy

Management of Women with Obesity in Pregnancy CMACE/RCOG Joint Guideline Management of Women with Obesity in Pregnancy March 2010 Centre for Maternal and Child Enquiries Improving the health of mothers, babies and children This guideline was produced on behalf of the Centre for Maternal and Child Enquiries and the Royal College of Obstetricians and Gynaecologists by: J Modder MRCOG, CMACE and KJ Fitzsimons Ph.D, CMACE and reviewed by the RCOG Guidelines Committee. The final version (...) is the responsibility of both CMACE and the Guidelines Committee of the RCOG. Updates of this guideline will be the responsibility of the Guidelines Committee of the RCOG. DISCLAIMERS CMACE ACKNOWLEDGEMENTS AND DISCLAIMER This work was undertaken by the Centre for Maternal and Child Enquiries (CMACE) as part of the CEMACH programme. The work was funded by the National Patient Safety Agency; the Department of Health, Social Services and Public Safety of Northern Ireland; NHS Quality Improvement Scotland (NHS QIS

2010 Royal College of Obstetricians and Gynaecologists

145. An “un-American suppression” of antivaccine views or good reporting?

) on 23 Mar 2015 to post comments By Robert L Bell (not verified) on 23 Mar 2015 to post comments By Robert L Bell (not verified) on 23 Mar 2015 to post comments By J.W.Chaplin (not verified) on 23 Mar 2015 , and in those who cannot be vaccinated for other medical reasons (the clue is in the words). As for the small minority for whom vaccines are not effective, I wasn't suggesting that vaccines are contraindicated for them, but keeping vaccine uptake levels high enough will protect them despite (...) , but now hardly any do. Why did the number of bacterial meningitis cases I saw in the hospitals I have worked in plummet after vaccination was introduced? I could go on. It disgusts me that anyone can deny what an astonishingly effective health intervention vaccination has been - . to post comments By Krebiozen (not verified) on 23 Mar 2015 to post comments By Krebiozen (not verified) on 23 Mar 2015 Now how do you respond to new (2009) NICE guidelines telling doctors not to dish out antipyretics

2015 Respectful Insolence

146. Neuraceq - florbetaben (18F)

. The Scientific Advice pertained to clinical aspects of the dossier. Neuraceq EMA/5028/2014 Page 6/114 Licensing status The product was not licensed in any country at the time of submission of the application. 1.2. Manufacturers Manufacturers responsible for batch release BV Cyclotron VU De Boelelaan 1081 1081 Amsterdam Netherlands CIS BIO INTERNATIONAL - PARIS 14 rue de la Grange aux Belles 75010 PARIS France IBA MOLECULAR ITALY c/o Ospedale San Gerardo dei Tintori VIA PERGOLESI,33 20052 Monza Italy Alliance (...) during the synthesis. The characterisation of the active substance and its impurities are in accordance with the EU guideline on chemistry of new active substances. Potential and actual impurities were well discussed with regards to their origin and characterised. Adequate specifications and control methods for intermediate products, starting materials and reagents have been presented. Adequate specification of the IFP (Integrated Fluidic Processor) including inspection of absence of defects

2014 European Medicines Agency - EPARs

147. Care of the Patient with Ocular Surface Disorders

blinking, which results in excessive tear evaporation and exposure keratopathy, can be caused by Bell's palsy, lagophthalmos, thyroid-related eye disease, foreign body, or lid trauma. Other lid abnormalities that prevent efficient resurfacing of the tear layer include ptosis, trichiasis, and madarosis. Statement of the Problem 11 d. Epitheliopathies Corneal epitheliopathies are characterized by an irregular epithelial surface where microvilli are prevented from allowing mucin to adhere to the cornea (...) Care of the Patient with Ocular Surface Disorders Care of the Patient with Ocular Surface Disorders OPTOMETRIC CLINICAL PRACTICE GUIDELINE OPTOMETRY: THE PRIMARY EYE CARE PROFESSION Doctors of optometry are independent primary health care providers who examine, diagnose, treat, and manage diseases and disorders of the visual system, the eye, and associated structures as well as diagnose related systemic conditions. Optometrists provide more than two-thirds of the primary eye care services

2010 American Optometric Association

148. Carotid Artery Stenting in Patients with Carotid Artery Stenosis

functional independence. 107 Major strokes have been defined as deficits that persisted beyond 30 days and that caused a change in the patient’s lifestyle. Other outcomes include degree of residual stenosis on immediate post-angioplasty angiography, recurrence of carotid stenosis on follow-up Doppler ultrasonography or angiography and occurrence of procedure-related complications such as myocardial infarction, cranial nerve palsies, arrhythmias and bleeding complications. Complications have been defined (...) ), cranial nerve palsies, long-term cognitive function and quality of life. Randomized Trials High quality, randomized controlled trials provide the most reliable data for evaluating the effectiveness of carotid artery stenting. There are only two small randomized trials comparing stent placement with medical management. 108, 109 Although underpowered, both reported no trend towards a reduction in strokes among patients treated with carotid stenting compared with those treated with medical management

2010 California Technology Assessment Forum

149. CPG on the comprehensive care of people with Alzheimer's Disease and other Dementias

CPG on the comprehensive care of people with Alzheimer's Disease and other Dementias Clinical Practice Guideline on the Comprehensive Care of People with Alzheimer’s Disease and other Dementias CLINICAL PRACTICE GUIDELINTES IN THE NHS MINISTRY OF HEALTH, SOCIAL SERVICES AND EQUALITY MINISTERIO DE SANIDAD, POLÍTICA SOCIAL E IGUALDADIt has been 5 years since the publication of this Clinical Practice Guideline and it is subject to updating. Clinical Practice Guideline on the Comprehensive Care (...) of People with Alzheimer’s Disease and other Dementias CLINICAL PRACTICE GUIDELINTES IN THE NHS MINISTRY OF HEALTH, SOCIAL SERVICES AND EQUALITY MINISTERIO DE SANIDAD, POLÍTICA SOCIAL E IGUALDAD It has been 5 years since the publication of this Clinical Practice Guideline and it is subject to updating. This CPG is a healthcare decision aid. It is not mandatory and it is not a substitute for the clinical judgement of healthcare personnel. Published by: Ministry of Science and Innovation INOP: In process

2010 GuiaSalud

150. Neoadjuvant Therapy in TRIPle Negative Breast Cancer With antiPDL1

in Chinese hamster ovary cells or any component of the MPDL3280A formulation Patients with prior allogeneic stem cell or solid organ transplantation History of autoimmune disease including, but not limited to, systemic lupus erythematosus, rheumatoid arthritis, inflammatory bowel disease, vascular thrombosis associated with antiphospholipid syndrome, Wegener's granulomatosis, Sjögren's syndrome, Bell's palsy, Guillain-Barré syndrome, multiple sclerosis, vasculitis, or glomerulonephritis History (...) and/or uterus): agreement to remain abstinent or use single or combined contraceptive methods that result in a failure rate of < 1% per year during the treatment period and for at least 90 days after the last dose of study drug. Exclusion Criteria: Evidence of bilateral breast cancer or metastatic disease (M1) Cases with an histology different from invasive ductal NOS of high proliferation or grade Patients with HER2-positive disease according to ASCO/CAP guidelines 2013 Pregnant or lactating women

2015 Clinical Trials

151. Nasopharyngeal Cancer, Childhood

summaries for specific information about supportive care for children and adolescents with cancer.) Guidelines for pediatric cancer centers and their role in the treatment of pediatric patients with cancer have been outlined by the American Academy of Pediatrics.[ ] At these pediatric cancer centers, clinical trials are available for most types of cancer that occur in children and adolescents, and the opportunity to participate in these trials is offered to most patients and their families. Clinical (...) al.: Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol 28 (15): 2625-34, 2010. Corrigan JJ, Feig SA; American Academy of Pediatrics: Guidelines for pediatric cancer centers. Pediatrics 113 (6): 1833-5, 2004. Smith MA, Altekruse SF, Adamson PC, et al.: Declining childhood and adolescent cancer mortality. Cancer 120 (16): 2497-506, 2014. Ward E, DeSantis C, Robbins A, et al.: Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin 64

2012 PDQ - NCI's Comprehensive Cancer Database

152. Multiple Endocrine Neoplasia, Childhood

summaries for specific information about supportive care for children and adolescents with cancer.) Guidelines for pediatric cancer centers and their role in the treatment of pediatric patients with cancer have been outlined by the American Academy of Pediatrics.[ ] At these pediatric cancer centers, clinical trials are available for most types of cancer that occur in children and adolescents, and the opportunity to participate in these trials is offered to most patients and their families. Clinical (...) al.: Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol 28 (15): 2625-34, 2010. Corrigan JJ, Feig SA; American Academy of Pediatrics: Guidelines for pediatric cancer centers. Pediatrics 113 (6): 1833-5, 2004. Smith MA, Altekruse SF, Adamson PC, et al.: Declining childhood and adolescent cancer mortality. Cancer 120 (16): 2497-506, 2014. Ward E, DeSantis C, Robbins A, et al.: Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin 64

2012 PDQ - NCI's Comprehensive Cancer Database

153. Mesothelioma, Childhood

for specific information about supportive care for children and adolescents with cancer.) Guidelines for pediatric cancer centers and their role in the treatment of pediatric patients with cancer have been outlined by the American Academy of Pediatrics.[ ] At these pediatric cancer centers, clinical trials are available for most types of cancer that occur in children and adolescents, and the opportunity to participate in these trials is offered to most patients and their families. Clinical trials (...) al.: Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol 28 (15): 2625-34, 2010. Corrigan JJ, Feig SA; American Academy of Pediatrics: Guidelines for pediatric cancer centers. Pediatrics 113 (6): 1833-5, 2004. Smith MA, Altekruse SF, Adamson PC, et al.: Declining childhood and adolescent cancer mortality. Cancer 120 (16): 2497-506, 2014. Ward E, DeSantis C, Robbins A, et al.: Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin 64

2012 PDQ - NCI's Comprehensive Cancer Database

154. Midline Tract Carcinoma, Childhood

summaries for specific information about supportive care for children and adolescents with cancer.) Guidelines for pediatric cancer centers and their role in the treatment of pediatric patients with cancer have been outlined by the American Academy of Pediatrics.[ ] At these pediatric cancer centers, clinical trials are available for most types of cancer that occur in children and adolescents, and the opportunity to participate in these trials is offered to most patients and their families. Clinical (...) al.: Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol 28 (15): 2625-34, 2010. Corrigan JJ, Feig SA; American Academy of Pediatrics: Guidelines for pediatric cancer centers. Pediatrics 113 (6): 1833-5, 2004. Smith MA, Altekruse SF, Adamson PC, et al.: Declining childhood and adolescent cancer mortality. Cancer 120 (16): 2497-506, 2014. Ward E, DeSantis C, Robbins A, et al.: Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin 64

2012 PDQ - NCI's Comprehensive Cancer Database

155. Papillomatosis, Childhood

for specific information about supportive care for children and adolescents with cancer.) Guidelines for pediatric cancer centers and their role in the treatment of pediatric patients with cancer have been outlined by the American Academy of Pediatrics.[ ] At these pediatric cancer centers, clinical trials are available for most types of cancer that occur in children and adolescents, and the opportunity to participate in these trials is offered to most patients and their families. Clinical trials (...) al.: Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol 28 (15): 2625-34, 2010. Corrigan JJ, Feig SA; American Academy of Pediatrics: Guidelines for pediatric cancer centers. Pediatrics 113 (6): 1833-5, 2004. Smith MA, Altekruse SF, Adamson PC, et al.: Declining childhood and adolescent cancer mortality. Cancer 120 (16): 2497-506, 2014. Ward E, DeSantis C, Robbins A, et al.: Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin 64

2012 PDQ - NCI's Comprehensive Cancer Database

156. Head and Neck Cancer, Childhood

for specific information about supportive care for children and adolescents with cancer.) Guidelines for pediatric cancer centers and their role in the treatment of pediatric patients with cancer have been outlined by the American Academy of Pediatrics.[ ] At these pediatric cancer centers, clinical trials are available for most types of cancer that occur in children and adolescents, and the opportunity to participate in these trials is offered to most patients and their families. Clinical trials (...) al.: Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol 28 (15): 2625-34, 2010. Corrigan JJ, Feig SA; American Academy of Pediatrics: Guidelines for pediatric cancer centers. Pediatrics 113 (6): 1833-5, 2004. Smith MA, Altekruse SF, Adamson PC, et al.: Declining childhood and adolescent cancer mortality. Cancer 120 (16): 2497-506, 2014. Ward E, DeSantis C, Robbins A, et al.: Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin 64

2012 PDQ - NCI's Comprehensive Cancer Database

157. Gastrointestinal Stromal Tumors, Childhood

summaries for specific information about supportive care for children and adolescents with cancer.) Guidelines for pediatric cancer centers and their role in the treatment of pediatric patients with cancer have been outlined by the American Academy of Pediatrics.[ ] At these pediatric cancer centers, clinical trials are available for most types of cancer that occur in children and adolescents, and the opportunity to participate in these trials is offered to most patients and their families. Clinical (...) al.: Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol 28 (15): 2625-34, 2010. Corrigan JJ, Feig SA; American Academy of Pediatrics: Guidelines for pediatric cancer centers. Pediatrics 113 (6): 1833-5, 2004. Smith MA, Altekruse SF, Adamson PC, et al.: Declining childhood and adolescent cancer mortality. Cancer 120 (16): 2497-506, 2014. Ward E, DeSantis C, Robbins A, et al.: Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin 64

2012 PDQ - NCI's Comprehensive Cancer Database

158. Esthesioneuroblastoma, Childhood

summaries for specific information about supportive care for children and adolescents with cancer.) Guidelines for pediatric cancer centers and their role in the treatment of pediatric patients with cancer have been outlined by the American Academy of Pediatrics.[ ] At these pediatric cancer centers, clinical trials are available for most types of cancer that occur in children and adolescents, and the opportunity to participate in these trials is offered to most patients and their families. Clinical (...) al.: Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol 28 (15): 2625-34, 2010. Corrigan JJ, Feig SA; American Academy of Pediatrics: Guidelines for pediatric cancer centers. Pediatrics 113 (6): 1833-5, 2004. Smith MA, Altekruse SF, Adamson PC, et al.: Declining childhood and adolescent cancer mortality. Cancer 120 (16): 2497-506, 2014. Ward E, DeSantis C, Robbins A, et al.: Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin 64

2012 PDQ - NCI's Comprehensive Cancer Database

159. Stomach (Gastric) Cancer, Childhood

summaries for specific information about supportive care for children and adolescents with cancer.) Guidelines for pediatric cancer centers and their role in the treatment of pediatric patients with cancer have been outlined by the American Academy of Pediatrics.[ ] At these pediatric cancer centers, clinical trials are available for most types of cancer that occur in children and adolescents, and the opportunity to participate in these trials is offered to most patients and their families. Clinical (...) al.: Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol 28 (15): 2625-34, 2010. Corrigan JJ, Feig SA; American Academy of Pediatrics: Guidelines for pediatric cancer centers. Pediatrics 113 (6): 1833-5, 2004. Smith MA, Altekruse SF, Adamson PC, et al.: Declining childhood and adolescent cancer mortality. Cancer 120 (16): 2497-506, 2014. Ward E, DeSantis C, Robbins A, et al.: Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin 64

2012 PDQ - NCI's Comprehensive Cancer Database

160. Colorectal Cancer, Childhood

for specific information about supportive care for children and adolescents with cancer.) Guidelines for pediatric cancer centers and their role in the treatment of pediatric patients with cancer have been outlined by the American Academy of Pediatrics.[ ] At these pediatric cancer centers, clinical trials are available for most types of cancer that occur in children and adolescents, and the opportunity to participate in these trials is offered to most patients and their families. Clinical trials (...) al.: Outcomes for children and adolescents with cancer: challenges for the twenty-first century. J Clin Oncol 28 (15): 2625-34, 2010. Corrigan JJ, Feig SA; American Academy of Pediatrics: Guidelines for pediatric cancer centers. Pediatrics 113 (6): 1833-5, 2004. Smith MA, Altekruse SF, Adamson PC, et al.: Declining childhood and adolescent cancer mortality. Cancer 120 (16): 2497-506, 2014. Ward E, DeSantis C, Robbins A, et al.: Childhood and adolescent cancer statistics, 2014. CA Cancer J Clin 64

2012 PDQ - NCI's Comprehensive Cancer Database

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>